Feedback / Questions
AZD8205 - AstraZeneca
AZD8205: Data from P1/2 trial (NCT05123482) for solid tumors post 2025
(AstraZeneca)
-
Apr 30, 2024 -
Q1 2024 Results
P1/2 data
•
Oncology • Solid Tumor
http://file:///C:/Users/Dell/Downloads/Q1-2024-results-clinical-trials-appendix%20(1).pdf
Apr 30, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious